Philipp Marchand
PARTNER, German, European and Swiss Patent Attorney, UPC Representative His practice is focused on strategic portfolio advice and value generation through IP. He also regularly prepares portfolio and risk assessments for investors and capital providers. He contributed the Swiss chapter to the book “Antibody Patenting: A Practitioner's Guide to Drafting, Prosecution and Enforcement” (Kluwer Law International, 2023). Furthermore, he is the author of several articles on patent law topics and regular speaker, particularly in the field of artificial intelligence and its impact on patent law. · Vossius & Partner
About
Partner at Vossius & Partner based in Germany. German, European and Swiss patent attorney and UPC Representative focusing on strategic IP portfolio advice and value generation, including portfolio and risk assessments for investors and capital providers; author and speaker on patent law and AI, and contributor to the Swiss chapter of Antibody Patenting (Kluwer, 2023).
Practice areas
Office
Expertise
Education
- Studied Biochemistry, TU Darmstadt and University of Frankfurt am Main (graduated 2008; membrane biophysics and solid-state NMR)
- Doctorate (Dr.) conducted at Institut de chimie des substances naturelles (ICSN), Gif‑sur‑Yvette and École Polytechnique, Palaiseau (2009–2012)
Admissions
- German Patent Attorney
- European Patent Attorney
- Swiss Patent Attorney
- UPC Representative
- Accredited Innosuisse Special Coach for IP (Switzerland)